PROPRIETARY SOFTWARE LICENSE

Copyright (c) 2024 [Your Organization Name]. All Rights Reserved.

NOTICE: This software and associated documentation files (the "Software")
are proprietary and confidential. The Software is licensed, not sold.

1. LICENSE GRANT
   Subject to the terms of this license, [Your Organization Name] grants
   you a non-exclusive, non-transferable, limited license to use the
   Software solely for xenotransplantation donor pig pathogen screening
   in compliance with PMDA guidelines.

2. RESTRICTIONS
   You may not:
   a) Distribute, sublicense, rent, lease, or lend the Software
   b) Modify, reverse engineer, decompile, or disassemble the Software
   c) Remove any proprietary notices or labels on the Software
   d) Use the Software for any purpose other than stated in Section 1
   e) Transfer the Software to any third party without written consent

3. OWNERSHIP
   [Your Organization Name] retains all right, title, and interest in and
   to the Software, including all intellectual property rights therein.

4. CONFIDENTIALITY
   The Software contains trade secrets and proprietary information. You
   agree to maintain the confidentiality of the Software and not disclose
   it to any third party.

5. COMPLIANCE
   Use of this Software must comply with:
   - PMDA xenotransplantation guidelines
   - Japanese Act on the Protection of Personal Information (APPI)
   - Relevant biosafety and biosecurity regulations
   - Good Laboratory Practice (GLP) standards where applicable

6. DATA PROTECTION
   Any patient or animal data processed using this Software must be:
   - Properly anonymized or pseudonymized
   - Stored securely with appropriate access controls
   - Handled in compliance with applicable data protection laws
   - Deleted or returned upon license termination

7. WARRANTY DISCLAIMER
   THE SOFTWARE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EXPRESS
   OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY,
   FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

8. LIMITATION OF LIABILITY
   IN NO EVENT SHALL [YOUR ORGANIZATION NAME] BE LIABLE FOR ANY SPECIAL,
   INCIDENTAL, INDIRECT, OR CONSEQUENTIAL DAMAGES, INCLUDING BUT NOT
   LIMITED TO LOSS OF DATA, BUSINESS INTERRUPTION, OR LOSS OF PROFITS.

9. INDEMNIFICATION
   You agree to indemnify and hold harmless [Your Organization Name] from
   any claims arising from your use of the Software.

10. AUDIT RIGHTS
    [Your Organization Name] reserves the right to audit your use of the
    Software to ensure compliance with this license.

11. TERMINATION
    This license will terminate automatically if you fail to comply with
    any term herein. Upon termination, you must cease all use of the
    Software and destroy all copies.

12. EXPORT CONTROL
    The Software may be subject to export control laws and regulations.
    You agree to comply with all applicable export laws.

13. GOVERNING LAW
    This license shall be governed by the laws of Japan, without regard
    to conflict of law principles.

14. ENTIRE AGREEMENT
    This license constitutes the entire agreement between the parties and
    supersedes all prior agreements relating to the Software.

15. CLINICAL USE DISCLAIMER
    THE SOFTWARE IS FOR RESEARCH AND DEVELOPMENT PURPOSES. ANY CLINICAL
    USE MUST BE SEPARATELY VALIDATED AND APPROVED BY RELEVANT REGULATORY
    AUTHORITIES.

16. THIRD-PARTY COMPONENTS
    The Software may include third-party components licensed under
    separate terms. See THIRD_PARTY_LICENSES.txt for details.

17. CONTACT INFORMATION
    For licensing inquiries:
    Email: licensing@your-org.com
    Address: [Your Organization Address]

18. PMDA COMPLIANCE NOTICE
    This Software is designed to support PMDA-compliant pathogen screening
    for xenotransplantation. Users are responsible for ensuring their
    specific implementation meets all regulatory requirements.

BY USING THE SOFTWARE, YOU ACKNOWLEDGE THAT YOU HAVE READ THIS LICENSE,
UNDERSTAND IT, AND AGREE TO BE BOUND BY ITS TERMS AND CONDITIONS.

---

SPECIAL PROVISIONS FOR CLINICAL TRIAL USE:

If this Software is used in clinical trials:

A. REGULATORY COMPLIANCE
   - Must comply with ICH-GCP guidelines
   - Must maintain 21 CFR Part 11 compliance where applicable
   - Must ensure data integrity per ALCOA+ principles

B. VALIDATION REQUIREMENTS
   - Software must be validated per intended use
   - Validation documentation must be maintained
   - Changes must be managed through formal change control

C. DATA RETENTION
   - Clinical trial data must be retained per regulatory requirements
   - Minimum 15 years after trial completion
   - Must be accessible for regulatory inspection

D. ADVERSE EVENT REPORTING
   - Any software malfunction affecting patient safety must be reported
   - Reporting timelines per applicable regulations
   - Maintain records of all reported events

---

Last Updated: January 15, 2024
Version: 1.0.0